chr6-160258390-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_003058.4(SLC22A2):c.368G>A(p.Arg123Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,848 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003058.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A2 | NM_003058.4 | c.368G>A | p.Arg123Gln | missense_variant | 1/11 | ENST00000366953.8 | NP_003049.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A2 | ENST00000366953.8 | c.368G>A | p.Arg123Gln | missense_variant | 1/11 | 1 | NM_003058.4 | ENSP00000355920 | P1 | |
SLC22A2 | ENST00000366952.1 | c.305G>A | p.Arg102Gln | missense_variant | 3/8 | 5 | ENSP00000355919 | |||
SLC22A2 | ENST00000489644.1 | n.350G>A | non_coding_transcript_exon_variant | 1/2 | 3 | |||||
SLC22A2 | ENST00000491092.1 | n.369G>A | non_coding_transcript_exon_variant | 1/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000522 AC: 13AN: 248872Hom.: 0 AF XY: 0.0000667 AC XY: 9AN XY: 134950
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461492Hom.: 1 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727050
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74506
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at